THCTenet Healthcare Corporation
Is it safe?
Strong, no red flags: a safe balance sheet.
Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Insiders were net sellers (-$50.0M, 90 days to Oct 8, 2026), selling is often routine.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Moderate price swings, typical volatility. Worst drawdown -72% · now 6% below its 52-week high.
Unless marked, from SEC EDGAR, as of Dec 31, 2025.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can THC take a bad year?
Tenet Healthcare Corporation carries $11.1B of net debt at 2.04× EBITDA: a load its earnings can carry.
Net debt · as at Q2 2026 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 2.04×
Net debt / EBITDA · 2.35× a year ago · the load is coming down
- Altman Z-score
- 1.86
Altman Z-score · grey zone, between 1.8 and 3
- Interest cover
- 5.54×
Interest cover · operating profit covers the interest bill several times over
Details›
- Total debtQ2 2026
- $13.2B
- Cash and short-term investments
- $2.17B
- Net debt
- $11.1B
- EBITDA, trailing twelve months
- $5.43B
- Operating profit, trailing twelve months
- $4.54B
- Debt / equity
- 2.84×
- Total debt / EBITDA
- 2.44×
- Annualised volatilitytwo years of daily moves
- 45%
- Worst drawdown on file
- −72%
- Below its 52-week high
- 6.0%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.